Navigation Links
Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
Date:1/25/2009

need for safe and effective treatments for drug resistant bacterial infections in the hospital and in the community."

About Trius Therapeutics

Trius Therapeutics is discovering and developing innovative antibacterial drugs for the treatment of infections caused by drug-resistant pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against drug-resistant Gram-positive bacterial pathogens including those resistant to Zyvox(R), the only marketed antibacterial drug of the oxazolidinone class. Trius has licensed worldwide rights outside of Korea to torezolid from Dong-A Pharmaceuticals. Trius' pipeline includes two preclinical programs with lead candidates being developed to treat serious infections caused by Gram-negative bacterial pathogens. For more information, visit www.triusrx.com.


'/>"/>
SOURCE Trius Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
2. PacificGMP Completes GMP Product Fill for Trius Therapeutics
3. Trius Doses First Patient in Antibacterial Phase 2 Trial
4. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
11. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015   Emerson Ecologics, LLC ... supplements, prescription products and natural health and ... with Anabolic Laboratories, a leading manufacturer of ... new partnership will allow Anabolic Laboratories to ... practitioner segments and provide customers with added ...
(Date:3/2/2015)... Calif. , March 2, 2015 Nevro ... company that has developed and commercialized an innovative, evidence-based ... announced that Brad Vale , PhD, DVM, former ... been appointed to its Board of Directors, effective March ... 30 years of experience in developing, commercializing and investing ...
(Date:3/2/2015)... 2015  BC Technical, the nation,s leading non-OEM ... Systems, a Nuclear Imaging service company providing systems, ... their ongoing vision to provide the best, and ... Technical continues to expand their reach and expertise. ... valuable resources and knowledge in addition to strengthening ...
Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3Nevro Appoints Dr. Brad Vale to its Board of Directors 2BC Technical Acquires Eclipse Systems 2
... 10 Biopure Corporation,(Nasdaq: BPUR ) today announced ... have been published in the June 2008 issue of,the ... an Alternative,to Blood Transfusion: Efficacy and Safety Evaluation in ... "It is gratifying to have experts cull through the ...
... Endpoints for Advair Diskus(R) ... Compared to ... African American,patients with asthma treated with Advair Diskus, a combination ... propionate, had a lower rate of exacerbations when,compared with patients ...
Cached Medicine Technology:Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma 2Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma 2Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma 3
(Date:3/2/2015)... Clearwater, FL (PRWEB) March 02, 2015 ... comply with Title VI of the Civil Rights Act, ... (LEP) and hearing loss are bringing light to the ... Bureau statistics reveal that nearly 1 in 20 U.S. ... 1 in 10 in some major cities.(1) Stratus ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Doctors in ... be a better predictor of outcomes for people with ... read details of the new study on the ... at the University of Eastern Piedmont followed the cases ... pleurodesis treatment for excess lung fluid. , “Persistent ...
(Date:3/2/2015)... Gummy smile reduction expert, Dr. ... can involve one or several procedures to reduce the appearance ... for a more even gum line. Dr. Farnoosh is the ... that can permanently lighten discolored or naturally dark gums. ... a personalized treatment plan to address a patient’s specific needs ...
(Date:3/2/2015)... 2015 After a rigorous evaluation process ... pricing and long-term strategy, Blood Centers of America (BCA) ... for member centers’ testing needs. , BCA, which comprises ... than 30 percent of the U.S. blood supply, made ... is committed to drive cost savings to members,” said ...
(Date:3/2/2015)... 2015 New York singer/songwriter Richie ... delivering a plenary address entitled Finding the Music ... of Healing and Recovery at this year’s National ... Executive Summit (BHES).     , With more than 300 ... been recorded by some of the biggest names ...
Breaking Medicine News(10 mins):Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2
... afflicting as many as 3.4% of all adults. Like other ... to society, often leading to suicide, job loss, and criminal ... become worse over time. Scientists have found that ... this disorder in the short term, including Naltrexone, used to ...
... from Boston University School of Medicine (BUSM) have ... robotic-assisted radical prostatectomy (RARP) is considerably different when ... an open prostatectomy (OP). These findings, which are ... RARP and OP surgery, may have implications for ...
... therapy can completely eradicate some models of cancer, according ... published in the current issue of the British ... from the University of Hull and ETH Zurich ... vessels. When irradiated with light, the molecules create particles ...
... thinking and reasoning abilities of adults who survived childhood ... Survivor Study. Researchers hope the findings will lead to ... population. The work was led by St. Jude Children,s ... to show that childhood cancer survivors are particularly vulnerable ...
... 11, 2011 In a first-of-its-kind study with nuts, ... (ARS) of the United States Department of Agriculture (USDA) ... absorbed by the body. The findings indicate that ... originally thought further validating pistachios as one of ...
... April 10 (HealthDay News) -- An "organic" label on foods ... healthier and tastier, new research suggests. The study included ... were conventionally and organically produced chocolate sandwich cookies, plain yogurt ... but they were labeled as either "regular" or "organic." ...
Cached Medicine News:Health News:In it to win it? 2Health News:Researchers find anatomic differences after robotic-assisted radical prostatectomy 2Health News:Light, chemistry, action -- a new technique to target skin cancers? 2Health News:Fatigue and sleep woes worsen neurocognitive problems in childhood cancer survivors 2Health News:Fatigue and sleep woes worsen neurocognitive problems in childhood cancer survivors 3Health News:Pistachios deliver weight management support, heart health benefits 2Health News:'Organic' Label Seems to Make Food Taste Better 2
Excellent during IOL insertion while pushing the trailing haptic into position. Gently curved shaft and round handle....
Ideal for nucleus manipulation during phacoemulsification. Also used for manipulating and rotating IOLs within the anterior chamber. Round knurled handle...
Short, narrow paddle angled 45 degree inserts through the side port stab incision and is ideal for effective manipulation of the lens during anterior chamber phacoemulsification....
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique. Round knurled handle. Manufactured in titanium....
Medicine Products: